Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1272999
                    [Title] => Hepa B for diabetes patients tops vaccine recs
                    [Summary] => 
Major changes regarding the use of the human papillomavirus vaccine in males, the hepatitis B vaccine in adults with diabetes and the influenza vaccine in egg-allergic individuals are among the highlights in the 2012 Adult Immunization Schedule from the Advisory Committee on Immunization Practices. The recommendations were published online in the journal.

                    [DatePublished] => 2013-12-29 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 941075
                    [Title] => FDA committee considers Gardasil for anal cancer
                    [Summary] => 
The human papillomavirus vaccine Gardasil has moved closer to an indication for anal cancer prevention.

                    [DatePublished] => 2013-05-12 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 503688
                    [Title] => US regulators support Glaxo cancer vaccine
                    [Summary] => 
WASHINGTON (AP) – Drugmaker Merck probably will face U.S. competition for its vaccine Gardasil after federal experts recommended that rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical cancers.
                    [DatePublished] => 2009-09-10 11:40:13
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 484912
                    [Title] => WHO approves cervical cancer vaccine Cervarix
                    [Summary] => 
The World Health Organization has approved a cervical cancer vaccine made by GlaxoSmithKline, meaning UN agencies and partners can now officially buy millions of doses of the vaccine for poor countries worldwide.
                    [DatePublished] => 2009-07-09 20:14:07
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 482744
                    [Title] => Fawcett's death spotlights a rare cancer
                    [Summary] => 


ATLANTA (AP) -- The death of Farrah Fawcett has thrown a spotlight on anal cancer, a rare disease often linked to a sexually transmitted virus.
                    [DatePublished] => 2009-07-02 11:31:16
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 15529
                    [Title] => Second vaccine that combats cervical cancer virus launched in Southeast Asia
                    [Summary] => 
            
                    [DatePublished] => 2007-08-25 19:59:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Nation
                    [SectionUrl] => nation
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 11011
                    [Title] => In the shade of a rose
                    [Summary] => 
            
                    [DatePublished] => 2007-08-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1528254
                    [AuthorName] => Mitzi Borromeo
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 389607
                    [Title] => Parents can now protect their daughters from cervical cancer through vaccination
                    [Summary] => 



Pediatricians are now included in the forefront of battling one more potentially fatal disease. Human Papillomavirus (HPV) causes cancer of the cervix (the lower part of the uterus that connects to the vagina). When a female becomes infected with certain types of HPV and the virus does not go away on its own, abnormal cells can develop in the lining of the cervix. If not discovered early and treated, these abnormal cells can become cervical pre-cancers and then cancer. But HPV affects not only women but also men. Genital warts are usually flesh-colored growths.
                    [DatePublished] => 2007-03-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1097249
                    [AuthorName] => Dr. Lourdes Ann Dizon-Co
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 382143
                    [Title] => ACIP outlines plan for Gardasil vaccine
                    [Summary] => 


The quadrivalent human papil-lomavirus vaccine should be given to all girls at age 11-12, and to all female aged 13-26 who have not been previously vaccinated, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted at its June meeting. Merck’s Gardasil vaccine, licensed in early June, is now available.
                    [DatePublished] => 2007-01-28 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 357529
                    [Title] => Make cervical cancer vaccine available to Asian women, experts say
                    [Summary] => 

MACTAN CITY (AP) — Women in the Asia—Pacific region are desperately in need of a new vaccine that could decrease the incidence of cervical cancer by 70 percent, and governments and drug makers should reduce the cost of the expensive medicine, health experts said.


About 266,000 women in the region are stricken with cervical cancer each year — more than half of the total number of women afflicted worldwide — and 143,000 die each year, experts at a conference in the Philippines said Saturday.


                    [DatePublished] => 2006-09-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

        )

)

GARDASIL

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1272999
                    [Title] => Hepa B for diabetes patients tops vaccine recs
                    [Summary] => 
Major changes regarding the use of the human papillomavirus vaccine in males, the hepatitis B vaccine in adults with diabetes and the influenza vaccine in egg-allergic individuals are among the highlights in the 2012 Adult Immunization Schedule from the Advisory Committee on Immunization Practices. The recommendations were published online in the journal.

                    [DatePublished] => 2013-12-29 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 941075
                    [Title] => FDA committee considers Gardasil for anal cancer
                    [Summary] => 
The human papillomavirus vaccine Gardasil has moved closer to an indication for anal cancer prevention.

                    [DatePublished] => 2013-05-12 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 503688
                    [Title] => US regulators support Glaxo cancer vaccine
                    [Summary] => 
WASHINGTON (AP) – Drugmaker Merck probably will face U.S. competition for its vaccine Gardasil after federal experts recommended that rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical cancers.
                    [DatePublished] => 2009-09-10 11:40:13
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 484912
                    [Title] => WHO approves cervical cancer vaccine Cervarix
                    [Summary] => 
The World Health Organization has approved a cervical cancer vaccine made by GlaxoSmithKline, meaning UN agencies and partners can now officially buy millions of doses of the vaccine for poor countries worldwide.
                    [DatePublished] => 2009-07-09 20:14:07
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 482744
                    [Title] => Fawcett's death spotlights a rare cancer
                    [Summary] => 


ATLANTA (AP) -- The death of Farrah Fawcett has thrown a spotlight on anal cancer, a rare disease often linked to a sexually transmitted virus.
                    [DatePublished] => 2009-07-02 11:31:16
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 15529
                    [Title] => Second vaccine that combats cervical cancer virus launched in Southeast Asia
                    [Summary] => 
            
                    [DatePublished] => 2007-08-25 19:59:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Nation
                    [SectionUrl] => nation
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 11011
                    [Title] => In the shade of a rose
                    [Summary] => 
            
                    [DatePublished] => 2007-08-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1528254
                    [AuthorName] => Mitzi Borromeo
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 389607
                    [Title] => Parents can now protect their daughters from cervical cancer through vaccination
                    [Summary] => 



Pediatricians are now included in the forefront of battling one more potentially fatal disease. Human Papillomavirus (HPV) causes cancer of the cervix (the lower part of the uterus that connects to the vagina). When a female becomes infected with certain types of HPV and the virus does not go away on its own, abnormal cells can develop in the lining of the cervix. If not discovered early and treated, these abnormal cells can become cervical pre-cancers and then cancer. But HPV affects not only women but also men. Genital warts are usually flesh-colored growths.
                    [DatePublished] => 2007-03-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1097249
                    [AuthorName] => Dr. Lourdes Ann Dizon-Co
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 382143
                    [Title] => ACIP outlines plan for Gardasil vaccine
                    [Summary] => 


The quadrivalent human papil-lomavirus vaccine should be given to all girls at age 11-12, and to all female aged 13-26 who have not been previously vaccinated, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted at its June meeting. Merck’s Gardasil vaccine, licensed in early June, is now available.
                    [DatePublished] => 2007-01-28 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 357529
                    [Title] => Make cervical cancer vaccine available to Asian women, experts say
                    [Summary] => 

MACTAN CITY (AP) — Women in the Asia—Pacific region are desperately in need of a new vaccine that could decrease the incidence of cervical cancer by 70 percent, and governments and drug makers should reduce the cost of the expensive medicine, health experts said.


About 266,000 women in the region are stricken with cervical cancer each year — more than half of the total number of women afflicted worldwide — and 143,000 die each year, experts at a conference in the Philippines said Saturday.


                    [DatePublished] => 2006-09-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

        )

)

abtest